CALIFORNIA CAPITAL EQUITY, LLC
CIK 1517764 · last filed 2023-09-06
CALIFORNIA CAPITAL EQUITY, LLC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider bought $143.4K of HLGN.WS on Sep 6, 2023. Across all open-market trades the lifetime net is +$5.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.07B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.07B
3
10
$5.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Heliogen, Inc. (HLGN.WS) Delisted | 10%+ Owner | 946,275 | $0.02 | $17.6K | $5.08M | 7 | 2023-09-06 |
| IBRX | 10%+ Owner | 291,179,746 | $7.10 | $2.07B | $0 | 1 | 2022-12-14 |
| NantHealth, Inc. (NH) Delisted | 10%+ Owner | — | $1.35 | — | $0 | 1 | 2021-04-28 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-06 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +22,080 | $143.4K | EDGAR |
| 2023-06-26 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +1,902,753 | $438.2K | EDGAR |
| 2023-06-15 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +5,177,718 | $1.05M | EDGAR |
| 2023-06-09 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +11,205,294 | $2.56M | EDGAR |
| 2023-06-05 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +540,036 | $132.5K | EDGAR |
| 2023-04-10 | Heliogen, Inc. (HLGN.WS) Delisted | Buy (P) | +3,078,153 | $759.8K | EDGAR |
| 2022-12-14 | IBRX | Conv (C) | +39,947,680 | $226.50M | EDGAR |
| 2022-07-05 | Heliogen, Inc. (HLGN.WS) Delisted | Grant (A) | +76,973,958 | $0 | EDGAR |
| 2021-04-28 | NantHealth, Inc. (NH) Delisted | Buy (P) | — | $0 | EDGAR |
| 2011-06-16 | — | Buy (P) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.